SBRA · Categories · Downgrades
SBRA - Analyst downgrades
Sabra Health Care REIT Inc. (SBRA) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for SBRA
- Sabra Health Care REIT downgraded by TruistTruist downgraded Sabra Health Care REIT from Buy to Hold
- Sabra Health Care REIT downgraded by Citigroup with a new price targetCitigroup downgraded Sabra Health Care REIT from Buy to Neutral and set a new price target of $19.00
- Sabra Health Care REIT downgraded by TruistTruist downgraded Sabra Health Care REIT from Buy to Hold
- Sabra Health Care REIT downgraded by Mizuho with a new price targetMizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00
- Sabra Health Care REIT downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Sabra Health Care REIT from Outperform to Market Perform and set a new price target of $16.00
- Sabra Health Care REIT downgraded by JMP SecuritiesJMP Securities downgraded Sabra Health Care REIT from Mkt Outperform to Mkt Perform
- Sabra Health Care REIT downgraded by BofA Securities with a new price targetBofA Securities downgraded Sabra Health Care REIT from Neutral to Underperform and set a new price target of $13.00 from $15.00 previously
- Sabra Health Care REIT downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $13.00
- Sabra Health Care REIT downgraded by Jefferies with a new price targetJefferies downgraded Sabra Health Care REIT from Buy to Hold and set a new price target of $14.00 from $15.00 previously
- Sabra Health Care REIT downgraded by Barclays with a new price targetBarclays downgraded Sabra Health Care REIT from Overweight to Equal Weight and set a new price target of $14.00 from $16.00 previously